Arena Pharmaceuticals, Inc. (ARNA) Financial Statements (2024 and earlier)

Company Profile

Business Address 6154 NANCY RIDGE DRIVE
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:1,104,041739,565445,631271,30090,712156,184
Cash and cash equivalents219,544243,274161,037158,83790,712156,184
Short-term investments884,497496,291284,59488,240  
Other undisclosed cash, cash equivalents, and short-term investments   24,223  
Receivables  1,6545,0862,35720,1624,934
Inventory, net of allowances, customer advances and progress billings     6,7089,502
Inventory     6,7089,502
Contract with customer, asset, after allowance for credit loss   1,484
Disposal group, including discontinued operation    17,140  
Other undisclosed current assets35,26618,7158,524(9,517)2,3074,218
Total current assets:1,139,307759,934460,725281,280119,889174,838
Noncurrent Assets
Property, plant and equipment22,09025,12823,11430,13143,82871,828
Long-term investments and receivables 370,93882,41224,242  
Long-term investments 370,93882,41224,242  
Intangible assets, net (including goodwill)     2,3577,775
Intangible assets, net (excluding goodwill)     2,3577,775
Disposal group, including discontinued operation, noncurrent assets    1,233  
Other noncurrent assets29,32318,12310,3193,6222,9362,351
Deferred tax assets, net110,333   
Other undisclosed noncurrent assets    (1,233)  
Total noncurrent assets:51,413414,189226,17857,99549,12181,954
TOTAL ASSETS:1,190,7201,174,123686,903339,275169,010256,792
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities35,35125,49916,1817,91612,0548,334
Employee-related liabilities18,84614,3298,6225,2554,8205,118
Accounts payable12,0046,0436,1921,5995,9772,078
Accrued liabilities4,5015,1271,3671,0621,2571,138
Restructuring reserve     62 
Estimated litigation liability    24,000  
Disposal group, including discontinued operation    27,595  
Deferred revenue and credits1,11035,28821,425
Other undisclosed current liabilities22,72619,46813,73711,70616,47520,137
Total current liabilities:58,07744,96729,91872,32763,87949,896
Noncurrent Liabilities
Long-term debt and lease obligation:      
Liabilities, other than long-term debt10,96312,0781,3012,0562,98888,087
Deferred revenue and credits1,0672,16788,087
Other liabilities10,96312,0781,301989821 
Operating lease, liability  
Other undisclosed noncurrent liabilities 41,21145,61349,42657,74861,748 
Total noncurrent liabilities:52,17457,69150,72759,80464,73688,087
Total liabilities:110,251102,65880,645132,131128,615137,983
Equity
Equity, attributable to parent1,080,4691,071,465606,258207,14439,90453,542
Common stock65542424
Additional paid in capital2,587,4942,173,1542,106,9601,698,5431,441,7151,430,917
Accumulated other comprehensive income (loss)7001,303(155)(1,216)(3,099)(1,179)
Accumulated deficit(1,507,731)(1,102,997)(1,500,552)(1,490,187)(1,398,736)(1,376,220)
Equity, attributable to noncontrolling interest     491 
Total equity:1,080,4691,071,465606,258207,14440,39553,542
Other undisclosed liabilities and equity     65,267
TOTAL LIABILITIES AND EQUITY:1,190,7201,174,123686,903339,275169,010256,792

Income Statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues319806,43117,97021,337123,97538,326
Revenue, net1,7056,70019,726
Sublease income  
Cost of revenue (14,461)(791)(379)(13,860)(15,902)
Cost of goods and services sold     (9,297)(8,590)
Gross profit:319791,97017,17920,958110,11522,424
Operating expenses(426,958)(309,224)(161,962)(112,925)(127,261)(125,622)
Other undisclosed operating loss      
Operating income (loss):(426,639)482,746(144,783)(91,967)(17,146)(103,198)
Nonoperating income (expense)21,90525,1425,949(3,887)(5,750)(4,781)
Investment income, nonoperating24,00726,8728,772492290158
Other nonoperating income (expense)2,4213,0612,8721,7404721,415
Interest and debt expense(4,523)(4,791)(5,695)(6,119)(6,512)(6,828)
Other undisclosed income from continuing operations before equity method investments, income taxes     6,8926,828
Income (loss) from continuing operations before equity method investments, income taxes:(409,257)503,097(144,529)(101,973)(22,516)(107,979)
Other undisclosed income from continuing operations before income taxes4,5234,7915,695   
Income (loss) from continuing operations before income taxes:(404,734)507,888(138,834)(101,973)(22,516)(107,979)
Income tax expense (benefit)  (110,333)110,265   
Other undisclosed income from continuing operations    6,119  
Income (loss) from continuing operations:(404,734)397,555(28,569)(95,854)(22,516)(107,979)
Income (loss) before gain (loss) on sale of properties:(404,734)397,555(29,399)(92,732)(22,516)(107,979)
Income (loss) from discontinued operations   (830)3,122  
Other undisclosed net loss     (380) 
Net income (loss):(404,734)397,555(29,399)(92,732)(22,896)(107,979)
Net income attributable to noncontrolling interest    1,325380 
Net income (loss) available to common stockholders, diluted:(404,734)397,555(29,399)(91,407)(22,516)(107,979)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):(404,734)397,555(29,399)(92,732)(22,896)(107,979)
Other comprehensive income (loss) (764)1,469(113)   
Other undisclosed comprehensive income (loss)  (11)721,883(1,920) 
Comprehensive income (loss):(405,498)399,013(29,440)(90,849)(24,816)(107,979)
Comprehensive income, net of tax, attributable to noncontrolling interest    1,325380 
Other undisclosed comprehensive income (loss), net of tax, attributable to parent161    (4,087)
Comprehensive income (loss), net of tax, attributable to parent:(405,337)399,013(29,440)(89,524)(24,436)(112,066)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: